KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomarin Pharmaceutical (BMRN) Tax Provisions: 2009-2024

Historic Tax Provisions for Biomarin Pharmaceutical (BMRN) over the last 16 years, with Dec 2024 value amounting to $114.9 million.

  • Biomarin Pharmaceutical's Tax Provisions fell 84.42% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $158.9 million, marking a year-over-year increase of 129.69%. This contributed to the annual value of $114.9 million for FY2024, which is 449.31% up from last year.
  • Biomarin Pharmaceutical's Tax Provisions amounted to $114.9 million in FY2024, which was up 449.31% from $20.9 million recorded in FY2023.
  • Biomarin Pharmaceutical's Tax Provisions' 5-year high stood at $114.9 million during FY2024, with a 5-year trough of -$903.0 million in FY2020.
  • Its 3-year average for Tax Provisions is $47.9 million, with a median of $20.9 million in 2023.
  • Per our database at Business Quant, Biomarin Pharmaceutical's Tax Provisions tumbled by 1,172.53% in 2020 and then skyrocketed by 449.31% in 2024.
  • Biomarin Pharmaceutical's Tax Provisions (Yearly) stood at -$903.0 million in 2020, then surged by 98.75% to -$11.3 million in 2021, then soared by 171.12% to $8.0 million in 2022, then soared by 160.99% to $20.9 million in 2023, then skyrocketed by 449.31% to $114.9 million in 2024.